All Stories

  1. Determination of Loratadine and Its Active Metabolite in Plasma by LC/MS/MS: An Adapted Method for Children

    Article • Current Pharmaceutical Analysis, August 2020, Bentham Science Publishers

    Wei Zhao

  2. Precision therapy of 6‐mercaptopurine in Chinese children with acute lymphoblastic leukemia

    Article • British Journal of Clinical Pharmacology, February 2020, Wiley

    Wei Zhao

  3. Developmental Population Pharmacokinetics and Dosing Optimization of Cefepime in Neonates and Young Infants

    Article • Frontiers in Pharmacology, February 2020, Frontiers

    Wei Zhao

  4. Population Pharmacokinetic Analysis of Isoniazid among Pulmonary Tuberculosis Patients from China

    Article • Antimicrobial Agents and Chemotherapy, January 2020, ASM Journals

    Wei Zhao

  5. Off-label use of medicines in neonates, infants, children, and adolescents: a joint policy statement by the European Academy of Paediatrics and the European society for Developmental Perinatal and Pediatric Pharmacology

    Article • European Journal of Pediatrics, January 2020, Springer Science + Business Media

    Wei Zhao, Professor karel allegaert

  6. Developmental Pharmacogenetics of SLCO2B1 on Montelukast Pharmacokinetics in Chinese Children

    Article • Drug Design Development and Therapy, December 2019, Taylor & Francis

    Wei Zhao

  7. Off‐label use of tacrolimus in children with glomerular disease: Effectiveness, Safety and Pharmacokinetics

    Article • British Journal of Clinical Pharmacology, November 2019, Wiley

    Wei Zhao

  8. Population Pharmacokinetics of Ganciclovir after Valganciclovir Treatment in Children with Renal Transplant

    Article • Antimicrobial Agents and Chemotherapy, September 2019, ASM Journals

    Wei Zhao

  9. Population pharmacokinetic meta-analysis of individual data to design the first randomized efficacy trial of vancomycin in neonates and young infants

    Article • Journal of Antimicrobial Chemotherapy, May 2019, Oxford University Press (OUP)

    Wei Zhao, Professor karel allegaert

  10. Optimisation of vancomycin exposure in neonates based on the best level of evidence

    Article • Pharmacological Research, May 2019, Elsevier

    Wei Zhao

  11. Body Surface Area-Based Dosing Regimen of Caspofungin in Children: a Population Pharmacokinetics Confirmatory Study

    Article • Antimicrobial Agents and Chemotherapy, April 2019, ASM Journals

    Wei Zhao

  12. Population Pharmacokinetics and Dosing Optimization of Imipenem in Children with Hematological Malignancies

    Article • Antimicrobial Agents and Chemotherapy, April 2019, ASM Journals

    Wei Zhao

  13. Population Pharmacokinetics and Dosing Optimization of Amoxicillin in Neonates and Young Infants

    Article • Antimicrobial Agents and Chemotherapy, December 2018, ASM Journals

    Wei Zhao

  14. Population pharmacokinetics and dosing optimization of latamoxef in neonates and young infants

    Article • International Journal of Antimicrobial Agents, November 2018, Elsevier

    Wei Zhao

  15. Early target attainment of azithromycin therapy in children with lower respiratory tract infections

    Article • Journal of Antimicrobial Chemotherapy, July 2018, Oxford University Press (OUP)

    Wei Zhao

  16. Population Pharmacokinetics and Dosing Optimization of Azithromycin in Children with Community-Acquired Pneumonia

    Article • Antimicrobial Agents and Chemotherapy, June 2018, ASM Journals

    Wei Zhao

  17. Pharmacokinetics and safety of fluconazole and micafungin in neonates with systemic candidiasis: a randomized, open-label clinical trial

    Article • British Journal of Clinical Pharmacology, June 2018, Wiley

    Wei Zhao

  18. A Sensitive Microscale HPLC-UV Method for the Determination of Doxofylline and its Metabolites in Plasma: An Adapted Method for Therapeutic Drug Monitoring in Children

    Article • Current Pharmaceutical Analysis, June 2018, Bentham Science Publishers

    Wei Zhao

  19. Aciclovir CSF concentration in children with viral encephalitis: is it adequate?

    Article • Journal of Antimicrobial Chemotherapy, June 2018, Oxford University Press (OUP)

    Wei Zhao

  20. Population pharmacokinetics of tacrolimus in children with nephrotic syndrome

    Article • British Journal of Clinical Pharmacology, May 2018, Wiley

    Wei Zhao

  21. A microscale HPLC-UV method for the determination of latamoxef in plasma: An adapted method for therapeutic drug monitoring in neonates

    Article • Biomedical Chromatography, April 2018, Wiley

    Wei Zhao

  22. Population pharmacokinetics and dosing optimization of cefathiamidine in children with hematologic infection

    Article • Drug Design Development and Therapy, April 2018, Dove Medical Press

    Wei Zhao

  23. Principles and applications of pharmacometrics in drug evaluation in children

    Article • Therapies, April 2018, Elsevier

    Wei Zhao

  24. Off-label use of tacrolimus in children with Henoch-Schönlein purpura nephritis: a pilot study

    Article • Archives of Disease in Childhood, March 2018, BMJ

    Wei Zhao

  25. Developmental pharmacogenetics of CYP2C19 in neonates and young infants: omeprazole as a probe drug

    Article • British Journal of Clinical Pharmacology, March 2018, Wiley

    Wei Zhao

  26. Pilot Study of Model-Based Dosage Individualization of Ganciclovir in Neonates and Young Infants with Congenital Cytomegalovirus Infection

    Article • Antimicrobial Agents and Chemotherapy, March 2018, ASM Journals

    Wei Zhao

  27. Penetration of Cefotaxime into Cerebrospinal Fluid in Neonates and Young Infants

    Article • Antimicrobial Agents and Chemotherapy, February 2018, ASM Journals

    Wei Zhao

  28. Pharmacogenetics of post-transplant diabetes mellitus in children with renal transplantation treated with tacrolimus

    Article • Pediatric Nephrology, February 2018, Springer Science + Business Media

    Wei Zhao

  29. Population Pharmacokinetics of Cefotaxime and Dosage Recommendations in Children with Sickle Cell Disease

    Article • Antimicrobial Agents and Chemotherapy, January 2018, ASM Journals

    Wei Zhao

  30. Population Pharmacokinetics and Dosing Optimization of Ceftazidime in Infants

    Article • Antimicrobial Agents and Chemotherapy, January 2018, ASM Journals

    Wei Zhao

  31. Determination of cefoperazone and sulbactam in serum by HPLC-MS/MS: An adapted method for therapeutic drug monitoring in children

    Article • Biomedical Chromatography, December 2017, Wiley

    Wei Zhao

  32. Commentary on the MID3 Good Practices Paper

    Article • CPT Pharmacometrics & Systems Pharmacology, July 2017, Wiley

    Wei Zhao

  33. Posologie des antibiotiques chez le nouveau-né : variations des pratiques et comment y remédier ?

    Article • Archives de Pédiatrie, September 2016, Elsevier

    Wei Zhao

  34. A Population and Developmental Pharmacokinetic Analysis To Evaluate and Optimize Cefotaxime Dosing Regimen in Neonates and Young Infants

    Article • Antimicrobial Agents and Chemotherapy, August 2016, ASM Journals

    Wei Zhao

  35. Safety study of Ciprofloxacin in newborn mice

    Article • Regulatory Toxicology and Pharmacology, February 2016, Elsevier

    Wei Zhao

  36. Clinical Utility and Safety of a Model-Based Patient-Tailored Dose of Vancomycin in Neonates

    Article • Antimicrobial Agents and Chemotherapy, January 2016, ASM Journals

    Wei Zhao

  37. Pharmacodynamics of vancomycin for CoNS infection: experimental basis for optimal use of vancomycin in neonates

    Article • Journal of Antimicrobial Chemotherapy, January 2016, Oxford University Press (OUP)

    Wei Zhao

  38. Author’s Reply to Standing et al. Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design

    Article • Clinical Pharmacokinetics, November 2015, Springer Science + Business Media

    Wei Zhao

  39. Population pharmacokinetics and dosing optimization of teicoplanin in children with malignant haematological disease

    Article • British Journal of Clinical Pharmacology, September 2015, Wiley

    Wei Zhao

  40. How to use vancomycin optimally in neonates: remaining questions

    Article • Expert Review of Clinical Pharmacology, August 2015, Taylor & Francis

    Wei Zhao

  41. Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design

    Article • Clinical Pharmacokinetics, June 2015, Springer Science + Business Media

    Wei Zhao

  42. Cystatin C as a potential biomarker for dosing of renally excreted drugs

    Article • British Journal of Clinical Pharmacology, May 2015, Wiley

    Wei Zhao

  43. Therapeutic guidelines for prescribing antibiotics in neonates should be evidence-based: a French national survey

    Article • Archives of Disease in Childhood, January 2015, BMJ

    Wei Zhao

  44. Impact of Glutathione S-Transferase M1 and T1 on Anti-Tuberculosis Drug–Induced Hepatotoxicity in Chinese Pediatric Patients

    Article • PLoS ONE, December 2014, PLOS

    Wei Zhao

  45. Pilot Phase II study of mazindol in children with attention deficit/hyperactivity disorder

    Article • Drug Design Development and Therapy, December 2014, Taylor & Francis

    Wei Zhao

  46. Choosing the right dose of tacrolimus

    Article • Archives of Disease in Childhood, November 2014, BMJ

    Wei Zhao

  47. First Dose in Neonates: Are Juvenile Mice, Adults and In Vitro–In Silico Data Predictive of Neonatal Pharmacokinetics of Fluconazole

    Article • Clinical Pharmacokinetics, August 2014, Springer Science + Business Media

    Wei Zhao

  48. Population Pharmacokinetics of Ciprofloxacin in Neonates and Young Infants Less than Three Months of Age

    Article • Antimicrobial Agents and Chemotherapy, August 2014, ASM Journals

    Wei Zhao

  49. Dosage individualization in children: integration of pharmacometrics in clinical practice

    Article • World Journal of Pediatrics, August 2014, Springer Science + Business Media

    Wei Zhao

  50. A model‐based approach for the evaluation of once daily dosing of lamivudine in HIV‐infected children

    Article • British Journal of Clinical Pharmacology, April 2014, Wiley

    Oscar Della Pasqua, Wei Zhao

  51. Covariate effects and population pharmacokinetics of lamivudine in HIV‐infected children

    Article • British Journal of Clinical Pharmacology, April 2014, Wiley

    Oscar Della Pasqua, Wei Zhao

  52. Population Pharmacokinetics and Dosing Optimization of Vancomycin in Children with Malignant Hematological Disease

    Article • Antimicrobial Agents and Chemotherapy, March 2014, ASM Journals

    Wei Zhao

  53. Pharmacokinetics and dosage individualization of ganciclovir and valganciclovir in an infant with nephrotic syndrome associated with cytomegalovirus infection

    Article • Journal of Antimicrobial Chemotherapy, November 2013, Oxford University Press (OUP)

    Wei Zhao

  54. Amikacin Maturation Model as a Marker of Renal Maturation to Predict Glomerular Filtration Rate and Vancomycin Clearance in Neonates

    Article • Clinical Pharmacokinetics, September 2013, Springer Science + Business Media

    Wei Zhao

  55. The Importance of Knowing How Vancomycin is Measured When Interpreting Its Pharmacokinetic Results

    Article • Therapeutic Drug Monitoring, June 2013, Wolters Kluwer Health

    Wei Zhao

  56. Population pharmacokinetics of abacavir in infants, toddlers and children

    Article • British Journal of Clinical Pharmacology, May 2013, Wiley

    Oscar Della Pasqua, Wei Zhao

  57. Population pharmacokinetics of ciclosporin in Chinese children with aplastic anemia: effects of weight, renal function and stanozolol administration

    Article • Acta Pharmacologica Sinica, April 2013, Nature

    Wei Zhao

  58. External evaluation of population pharmacokinetic models of vancomycin in neonates: the transferability of published models to different clinical settings

    Article • British Journal of Clinical Pharmacology, March 2013, Wiley

    Professor karel allegaert , Wei Zhao

  59. Use of antibacterial agents in the neonate: 50 years of experience with vancomycin administration

    Article • Seminars in Fetal and Neonatal Medicine, February 2013, Elsevier

    Wei Zhao

  60. Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring

    Article • Archives of Disease in Childhood, December 2012, BMJ

    Wei Zhao

  61. Limited sampling strategy using Bayesian estimation for estimating individual exposure of the once-daily prolonged-release formulation of tacrolimus in kidney transplant children

    Article • European Journal of Clinical Pharmacology, December 2012, Springer Science + Business Media

    Wei Zhao

  62. Pharmacogenetic Determinant of the Drug Interaction Between Tacrolimus and Omeprazole

    Article • Therapeutic Drug Monitoring, December 2012, Wolters Kluwer Health

    Wei Zhao

  63. Optimizing Micafungin Dosing in Children

    Article • The Pediatric Infectious Disease Journal, November 2012, Wolters Kluwer Health

    Wei Zhao

  64. Population pharmacokinetics and pharmacogenetics of once daily prolonged-release formulation of tacrolimus in pediatric and adolescent kidney transplant recipients

    Article • European Journal of Clinical Pharmacology, June 2012, Springer Science + Business Media

    Wei Zhao

  65. Individualization of Valganciclovir Prophylaxis for Cytomegalovirus Infection in Pediatric Kidney Transplant Patients

    Article • Therapeutic Drug Monitoring, June 2012, Wolters Kluwer Health

    Wei Zhao

  66. Pharmacokinetic Interaction Between Tacrolimus and Amlodipine in a Renal Transplant Child

    Article • Transplantation, April 2012, Wolters Kluwer Health

    Wei Zhao

  67. Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir: application of individualized therapy in HIV‐infected infants and toddlers

    Article • British Journal of Clinical Pharmacology, March 2012, Wiley

    Oscar Della Pasqua, Wei Zhao

  68. Limited Sampling Strategy for Estimating Individual Exposure of Tacrolimus in Pediatric Kidney Transplant Patients

    Article • Therapeutic Drug Monitoring, December 2011, Wolters Kluwer Health

    Wei Zhao

  69. Paediatric drug development: are population models predictive of pharmacokinetics across paediatric populations?

    Article • British Journal of Clinical Pharmacology, August 2011, Wiley

    Oscar Della Pasqua, Wei Zhao

  70. Principles of Therapeutic Drug Monitoring

    Article • January 2011, Springer Science + Business Media

    Wei Zhao

  71. Developmental Pharmacogenetics of Immunosuppressants in Pediatric Organ Transplantation

    Article • Therapeutic Drug Monitoring, December 2010, Wolters Kluwer Health

    Wei Zhao

  72. Population Pharmacokinetics and Pharmacogenetics of Mycophenolic Acid Following Administration of Mycophenolate Mofetil in De Novo Pediatric Renal-Transplant Patients

    Article • The Journal of Clinical Pharmacology, November 2010, Wiley

    Wei Zhao

  73. Determination of ciprofloxacin in plasma by micro-liquid chromatography-mass spectrometry: An adapted method for neonates

    Article • Biomedical Chromatography, September 2010, Wiley

    Wei Zhao

  74. Population pharmacokinetics and Bayesian estimator of mycophenolic acid in children with idiopathic nephrotic syndrome

    Article • British Journal of Clinical Pharmacology, April 2010, Wiley

    Wei Zhao

  75. Pharmacokinetic study of once-daily versus twice-daily abacavir and lamivudine in HIV type-1-infected children aged 3-<36 months

    Article • Antiviral Therapy, January 2010, International Medical Press

    Wei Zhao

  76. Population Pharmacokinetics and Pharmacogenetics of Tacrolimus in De Novo Pediatric Kidney Transplant Recipients

    Article • Clinical Pharmacology & Therapeutics, October 2009, Nature

    Wei Zhao

  77. Population Pharmacokinetics of Ganciclovir Following Administration of Valganciclovir in Paediatric Renal Transplant Patients

    Article • Clinical Pharmacokinetics, May 2009, Springer Science + Business Media

    Wei Zhao